Articles published by Arcturus Therapeutics Holdings Inc.
Via Business Wire
Tickers
ARCT
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
November 11, 2024
Via Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
November 07, 2024
Via Business Wire
Tickers
ARCT
Via Business Wire
Via Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Second Quarter 2024 Financial Update and Pipeline Progress
August 05, 2024
Via Business Wire
Tickers
ARCT
Via Business Wire
Tickers
ARCT
Via Business Wire
Tickers
ARCT
Via Business Wire
Tickers
ARCT
Via Business Wire
Tickers
ARCT
Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
February 26, 2024
Via Business Wire
Tickers
ARCT
Arcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 04, 2023
Via Business Wire
Tickers
ARCT
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update and Pipeline Progress
November 14, 2023
Via Business Wire
Tickers
ARCT
Via Business Wire
Tickers
ARCT
Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants
September 19, 2023
Via Business Wire
Tickers
ARCT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.